Aster DM Healthcare , a leading integrated healthcare service provider in India, has reported robust financial results for the first quarter, along with significant strategic initiatives to strengthen its market position.

Q1 Financial Highlights

Aster DM Healthcare delivered a strong start to the fiscal year, with consolidated revenue growing 8% year-on-year to ₹1,078.00 crore in Q1. The company's operating EBITDA saw an impressive 21% increase to ₹215.00 crore, while profit after tax (PAT) rose by 22% compared to the same period last year.

Key operational metrics also showed positive momentum:

• Average Revenue Per Occupied Bed (ARPOB) increased by 14% year-on-year to ₹50,200.00
• Average Length of Stay (ALOS) improved by 4% to 3.1 days
• Occupancy stood at 59%, reflecting the addition of new beds and improved ALOS

Strategic Expansion in Bengaluru

In a significant move to strengthen its presence in South India, Aster DM Healthcare announced a ₹580.00 crore investment to establish its fifth hospital in Bengaluru. The new 500-bed, state-of-the-art facility will be located in Yeswanthpur, expanding the company's total bed capacity in the city to over 2,580 beds.

Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, commented on the expansion: "The announcement of the new hospital in Bengaluru marks a significant milestone in Aster's India growth journey. This strategic expansion will further solidify our position as one of the leading healthcare providers in the region."

Other Strategic Developments

• Aster DM Healthcare acquired an additional 13% stake in Aster Ramesh Hospitals, increasing its total shareholding from 57.49% to 70.49%.
• The company entered into a lease agreement for a composite property in Sarjapur Road, Bengaluru, to establish its fourth multispecialty hospital in the city.
• Aster Labs, the company's diagnostic arm, reported a 14% year-on-year revenue growth in Q1, maintaining a positive EBITDA margin of 7.6%.

Cluster Performance

Kerala Cluster

The Kerala cluster showed signs of recovery with a 5% year-on-year revenue growth in Q1, driven by a 6% quarter-on-quarter increase in in-patient volumes.

Karnataka & Maharashtra Cluster

The Karnataka & Maharashtra cluster continued its strong performance with a 13% year-on-year revenue growth and a 23% increase in operating EBITDA.

Outlook

Dr. Moopen expressed confidence in the company's growth trajectory, stating, "With these initiatives, we remain well-positioned for sustained growth. Our commitment to operational excellence, clinical innovation, and strategic expansions will allow us to redefine healthcare delivery in India."

Aster DM Healthcare's strong Q1 performance and strategic expansions underscore its commitment to growth and its aim to strengthen its position as a leading healthcare provider in India.

Aster DM Healthcare Limited , a leading healthcare service provider, has announced its financial results for the first quarter of fiscal year 2026, along with several strategic initiatives to strengthen its market position.

Q1 FY2026 Financial Highlights

Aster DM Healthcare reported a robust performance for the quarter ended June 30, 2025:

• Consolidated revenue from operations increased to INR 1,077.87 crore, up from INR 1,001.87 crore in the same quarter last year, marking a 7.6% year-on-year growth.
• Consolidated profit for the quarter stood at INR 93.56 crore, compared to INR 5,152.20 crore in the previous year's quarter. It's important to note that the prior year's profit included a significant gain from the disposal of business operations.
• On a standalone basis, revenue from operations rose to INR 613.04 crore, up from INR 565.62 crore in Q1 FY2025, showing an 8.4% increase.
• Standalone profit for the quarter was INR 80.59 crore, compared to INR 6,008.24 crore in the same period last year.

Dividend Declaration

The Board of Directors has approved a final dividend of INR 1.00 per equity share for the financial year 2024-25, subject to shareholder approval at the upcoming 17th Annual General Meeting scheduled for September 4, 2025. The record date for dividend eligibility and voting rights has been set for August 28, 2025.

Strategic Expansion and Asset Transfer

Aster DM Healthcare announced several strategic moves to enhance its operational capabilities:

1. Asset Transfer: The company approved the purchase of identified assets of Block D of Aster Whitefield Hospital from its wholly-owned subsidiary, Aster DM Multispecialty Hospital Private Limited (AMHPL), for a consideration not exceeding INR 80.00 crore. This transfer is aimed at operational and strategic optimization.

2. Increased Stake in Subsidiary: The company is set to acquire an additional 13% stake in Dr. Ramesh Cardiac & Multispecialty Hospital Pvt Ltd (DRCM), increasing its shareholding from 57.49% to 70.49%. This acquisition, valued at INR 63.01 crore, is in line with the put option exercised by DRCM's promoter group.

3. New Hospital Project: Aster DM Healthcare has entered into a lease agreement for a composite property in Yeshwanthpur, Bengaluru, to establish a new 500-bed super-specialty hospital. The project, with an estimated investment of INR 580.00 crore, is expected to be operational in the second half of FY 2028-29.

Corporate Governance Updates

The company has also amended several policies, including those related to related party transactions, materiality disclosures, and insider trading, reinforcing its commitment to strong corporate governance practices.

Dr. Azad Moopen, Chairman and Managing Director of Aster DM Healthcare, commented on the results, stating, "Our Q1 performance demonstrates the resilience of our business model and the success of our strategic initiatives. The expansion plans and operational optimizations we've announced today are aimed at strengthening our market position and enhancing shareholder value."

As Aster DM Healthcare continues to expand its footprint and optimize operations, investors and stakeholders will be keenly watching the company's progress in executing these strategic initiatives and their impact on future financial performance.